Skip to main content
TipRanks
Go Ultimate75% OFF

Douglas G Janzen Insider Profile

11 Followers

Douglas G Janzen, Chairman & Chief Executive Officer at Aequus Pharmaceuticals, holds 12.55M shares in Aequus Pharmaceuticals (Ticker: TSE:AQS), holds 182.50K shares in Correvio Pharma (Ticker: CORV), holds 40.00K shares in Satellos Bioscience (Ticker: MSLE). Most recently, Douglas G Janzen Bought ― shares of Aequus Pharmaceuticals on Dec 01, 2022 for an estimated value of C$14.85K.

Douglas G Janzen's Trading History

NVCN
Neovasc
Mar 24, 2023―Uninformative Sell―$1.17M
AQS
Aequus Pharmaceuticals
Dec 01, 2022Chairman & Chief Executive OfficerInformative Buy14.85KC$125.54K
PINK
Perimeter Medical Imaging AI
Jul 16, 2021DirectorInformative Buy162.35KC$21.33K
MSLE
Satellos Bioscience
―Director―$258.80K
CORV
Correvio Pharma
―――$76.47K

You May Also Like

Douglas G Janzen insider profile FAQ

What is the percentage of profitable transactions made by Douglas G Janzen?
The percentage of profitable transactions made by Douglas G Janzen is 19%.
What is the average return per transaction made by Douglas G Janzen?
The average return per transaction made by Douglas G Janzen is -21.40%.
What stocks does Douglas G Janzen hold?
Douglas G Janzen holds: TSE:AQS, CORV, MSLE, NVCN, TSE:PINK stocks.
What was Douglas G Janzen’s latest transaction?
Douglas G Janzen’s latest transaction was an Informative Buy of C$14.85K.
What was Douglas G Janzen's most profitable transaction?
Douglas G Janzen’s most profitable transaction was an Informative Sell of NVCN stock on November 24, 2015. The return on the trade was 88.80%.
What is Douglas G Janzen's role in Aequus Pharmaceuticals?
Douglas G Janzen's role in Aequus Pharmaceuticals is Chairman & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.